home / stock / jazz / jazz news


JAZZ News and Press, Jazz Pharmaceuticals plc

Stock Information

Company Name: Jazz Pharmaceuticals plc
Stock Symbol: JAZZ
Market: NASDAQ

Menu

JAZZ JAZZ Quote JAZZ Short JAZZ News JAZZ Articles JAZZ Message Board
Get JAZZ Alerts

News, Short Squeeze, Breakout and More Instantly...

JAZZ - Jazz presents additional phase 2 data on zanidatamab for biliary tract cancer

2024-06-01 17:13:06 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (u...

JAZZ - Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024

Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 PR Newswire Zanidatamab demonstrated a median overall survival (OS) of 15.5 month...

JAZZ - Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024

Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 PR Newswire Thirteen abstracts, including five late-breaking abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders Oral ...

JAZZ - Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences

Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences PR Newswire DUBLIN , May 29, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences...

JAZZ - Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer

Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer PR Newswire Target Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ ...

JAZZ - 3 Cannabis Stocks to Buy Now: May 2024

2024-05-26 10:09:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many ar...

JAZZ - Jazz Pharmaceuticals Announces Collaboration With Life Science Cares To Improve the Wellbeing of Under Resourced Communities Through Employee Volunteerism

Originally published by Jazz Pharmaceuticals DUBLIN, IRELAND / ACCESSWIRE / May 22, 2024 / Jazz Pharmaceuticals plc (Nasdaq:JAZZ) today announced a strategic collaboration with Life Science Cares to drive social impact through employee volunteerism in the United States. This partnership rei...

JAZZ - Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism

Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism PR Newswire DUBLIN , May 22, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a ...

JAZZ - (JAZZ) Trading Report

2024-05-22 03:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

JAZZ - 3 Cheap Blue-Chip Stocks to Buy Now: May 2024

2024-05-17 14:32:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If the market’s dramatic shifts this year leave you discombobulated, you’re not alone. But, despite widespread overvaluation across a range of tech stocks , plenty of cheap ...

Next 10